Research Nester Logo.jpg
Multiparameter Patient Monitoring Market revenue to reach USD 24 Billion by 2036, says Research Nester
February 15, 2024 07:30 ET | Research Nester
New York, Feb. 15, 2024 (GLOBE NEWSWIRE) -- The global multiparameter patient monitoring market size is slated to expand at ~8% CAGR between 2024 and 2036. The market is poised to garner a revenue...
Research Nester Logo.jpg
Behavioral Health Market revenue to surpass USD 67 Billion by 2033, says Research Nester
January 22, 2024 05:00 ET | Research Nester
New York, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The global behavioral health market size is projected to expand at ~5% CAGR between 2023 and 2033. The market is expected to garner a revenue of USD 67...
Newborn Metabolic Screening Market Size is Projected to Grow from US$ 295.7 Million in 2022 to US$ 757.9 Million by 2032, Exhibiting a CAGR of 8.9% | Persistence Market Research
January 22, 2024 03:15 ET | Persistence Market Research
New York, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Newborn Metabolic Screening Market Overview: The Newborn Metabolic Screening Market is a crucial component of newborn healthcare, aimed at detecting...
Erkim logo.jpg
Er-Kim Announces Exclusive Distribution Agreement with Ascendis Pharma A/S to Commercialize 3 Endocrinology Disease Treatments Across Central & Eastern Europe and Turkey
January 08, 2024 18:01 ET | Er-Kim
Er-Kim is appointed as the exclusive Ascendis A/S endocrinology distributor across Central & Eastern Europe and Turkey
Children's Hospital Los Angeles Campus
Accarent Health Announces Affiliation with Children’s Hospital Los Angeles to Provide Virtual Cardiology, Oncology and Musculoskeletal Second Opinion Services
January 02, 2024 10:57 ET | Accarent Health
Baltimore, MD, Jan. 02, 2024 (GLOBE NEWSWIRE) -- When your child has a health condition, you want the best possible care. Children’s Hospital Los Angeles (CHLA) provides exceptional family-centered...
Mithra logo.jpg
Mithra Completes Pediatric Study of ESTELLE® in Adolescent Patients
December 20, 2023 11:45 ET | Mithra Pharmaceuticals
Mithra Completes Pediatric Study of ESTELLE® in Adolescent Patients Important milestone for Mithra’s commitment to bring benefits of ESTELLE® to more womenPotential EMA approval in pediatric...
ABC Medical Headquarters
Behavioral Health Startup, ABC Medical, Offers Innovative Treatment Program
November 17, 2023 14:59 ET | ABC Medical
Comprehensive treatment program for those experiencing mental illness
RationalStat Logo 1.png
Pediatric Clinical Trials Market Size to Reach US$ 20.6 Billion by 2030, Driven by Increasing Prevalence of Chronic Diseases and Rising Demand for Pediatric-Specific Treatments
November 08, 2023 06:01 ET | Rationalstat LLC
Wilmington, Delaware, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Global Pediatric Clinical Trials Market value is estimated at US$ 14.6 billion in 2023 and is expected to grow at a significant CAGR...
NeuroSigma.png
NeuroSigma Announces FDA 510(k) Submission for Second Generation Monarch eTNS System
November 07, 2023 08:50 ET | NeuroSigma, Inc.
LOS ANGELES, Nov. 07, 2023 (GLOBE NEWSWIRE) -- NeuroSigma today announced it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for its second-generation...
Catalyst Pharmaceutical logo
Catalyst Pharmaceuticals Reports FDA Approval of AGAMREE® (vamorolone) for Duchenne Muscular Dystrophy Granted to Santhera Pharmaceuticals
October 26, 2023 15:19 ET | Catalyst Pharmaceuticals, Inc.
AGAMREE® Indicated for the Treatment of Duchenne Muscular Dystrophy for Patients Aged Two Years and Older Catalyst Holds the Exclusive North American License to Commercialize AGAMREE (vamorolone) for...